Medicines delisting: the PBAC principles

To guide its decisions on medicines delisting including those available OTC, the Department of Health has published principles set by the Pharmaceutical Benefits Advisory Committee. The delisting principles considered appropriate by the PBAC include: Schedule 2 or 3 OTC medicine; low ex-manufacturer price; products unlikely to be highly reliant on specialist prescribing and management; and,